drugset / Trial / NCT00037570

Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage

NCT00037570

Phase 2 Completed 12 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedPrevention

Summary

This is a multicenter, randomized, double-blind, parallel-group, dose-ranging, comparator-controlled study of the effect of pantoprazole on intragastric pH after successful endoscopic hemostasis in hospitalized patients. Patients will receive either intravenous pantoprazole (one of two regimens) or ranitidine (the comparator) within 2 hours of successful hemostasis and administration will continue for 72 hours after hemostasis.

Timeline

Start
2000-11
Primary completion
2002-02
Completion
2002-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Pantoprazole Other / unclassified Intravenous

Indications